Stanford University
The purpose of this open-label study is to evaluate the effects of a single intravenous infusion of ketamine on depression and anxiety in adults with low vision.
Inclusion Criteria for Participants with Low Vision: * Ages 18 and older * Qualifies as a low vision participant based on ophthalmology assessments * Capacity to provide informed consent Inclusion Criteria for Healthy Controls: * Ages 18 and older * Qualifies as a normal vision participant based on ophthalmology assessments * Capacity to provide informed consent * Likely able to tolerate clinical study procedures * No current or lifetime psychiatric diagnosis * No current or past use of psychotropic medication Exclusion Criteria for Participants with Low Vision and Healthy Controls: * all…
Single intravenous racemic ketamine hydrochloride, 0.5 mg/kg in 100 ml of normal saline, infused over 40 minutes with continuous monitoring of vital signs.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.